Sanofi Genzyme to Resume Clinical Trials of Hemophilia Drug Fitusiran with Optimized Dosing …,

They noted that on October 30, they had “voluntarily paused dosing in all ongoing fitusiran clinical studies … to assess reports of non-fatal thrombotic …, They noted that on October 30, they had “voluntarily paused dosing in all ongoing fitusiran clinical studies … to assess reports of non-fatal thrombotic …, Read More

Scroll to Top